nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CALR—esophageal cancer	0.428	0.726	CbGaD
Melatonin—CYP1B1—esophageal cancer	0.0933	0.158	CbGaD
Melatonin—MPO—Carboplatin—esophageal cancer	0.0911	0.424	CbGbCtD
Melatonin—MPO—Cisplatin—esophageal cancer	0.0778	0.362	CbGbCtD
Melatonin—CYP19A1—esophageal cancer	0.0685	0.116	CbGaD
Melatonin—SLC22A8—Methotrexate—esophageal cancer	0.0185	0.0864	CbGbCtD
Melatonin—CYP2C9—Capecitabine—esophageal cancer	0.0181	0.0845	CbGbCtD
Melatonin—CYP2C9—Cisplatin—esophageal cancer	0.00914	0.0425	CbGbCtD
Melatonin—CALR—exocrine gland—esophageal cancer	0.00332	0.0693	CbGeAlD
Melatonin—EPX—digestive system—esophageal cancer	0.00247	0.0516	CbGeAlD
Melatonin—CALR—neck—esophageal cancer	0.00212	0.0443	CbGeAlD
Melatonin—EPX—lung—esophageal cancer	0.00206	0.0431	CbGeAlD
Melatonin—ASMT—digestive system—esophageal cancer	0.00205	0.0428	CbGeAlD
Melatonin—IDO1—digestive system—esophageal cancer	0.00187	0.0391	CbGeAlD
Melatonin—IDO1—lung—esophageal cancer	0.00156	0.0327	CbGeAlD
Melatonin—CALR—epithelium—esophageal cancer	0.00144	0.0301	CbGeAlD
Melatonin—CALR—bronchus—esophageal cancer	0.00142	0.0297	CbGeAlD
Melatonin—CALR—smooth muscle tissue—esophageal cancer	0.00139	0.029	CbGeAlD
Melatonin—CALR—trachea—esophageal cancer	0.00128	0.0267	CbGeAlD
Melatonin—MT3—lung—esophageal cancer	0.00116	0.0243	CbGeAlD
Melatonin—CALR—digestive system—esophageal cancer	0.0011	0.0229	CbGeAlD
Melatonin—IDO1—lymph node—esophageal cancer	0.00107	0.0223	CbGeAlD
Melatonin—CALM2—exocrine gland—esophageal cancer	0.00102	0.0212	CbGeAlD
Melatonin—CALM1—exocrine gland—esophageal cancer	0.00101	0.0211	CbGeAlD
Melatonin—CALR—lung—esophageal cancer	0.000917	0.0192	CbGeAlD
Melatonin—Gastrointestinal tract irritation—Capecitabine—esophageal cancer	0.00085	0.025	CcSEcCtD
Melatonin—NQO2—bronchus—esophageal cancer	0.000802	0.0167	CbGeAlD
Melatonin—MT3—lymph node—esophageal cancer	0.000795	0.0166	CbGeAlD
Melatonin—NQO2—trachea—esophageal cancer	0.00072	0.015	CbGeAlD
Melatonin—Nabumetone—PTGS1—esophageal cancer	0.000692	0.541	CrCbGaD
Melatonin—Depressed mood—Capecitabine—esophageal cancer	0.000679	0.0199	CcSEcCtD
Melatonin—Prurigo—Capecitabine—esophageal cancer	0.000658	0.0193	CcSEcCtD
Melatonin—ESR1—neck—esophageal cancer	0.000654	0.0137	CbGeAlD
Melatonin—CALM2—neck—esophageal cancer	0.00065	0.0136	CbGeAlD
Melatonin—CALM1—neck—esophageal cancer	0.000647	0.0135	CbGeAlD
Melatonin—CALR—lymph node—esophageal cancer	0.000627	0.0131	CbGeAlD
Melatonin—MPO—epithelium—esophageal cancer	0.000627	0.0131	CbGeAlD
Melatonin—Night sweats—Capecitabine—esophageal cancer	0.000562	0.0165	CcSEcCtD
Melatonin—CALM3—bronchus—esophageal cancer	0.000555	0.0116	CbGeAlD
Melatonin—CALM3—smooth muscle tissue—esophageal cancer	0.000543	0.0113	CbGeAlD
Melatonin—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.000529	0.0155	CcSEcCtD
Melatonin—NQO2—lung—esophageal cancer	0.000517	0.0108	CbGeAlD
Melatonin—Visual acuity reduced—Capecitabine—esophageal cancer	0.00051	0.015	CcSEcCtD
Melatonin—CALM3—trachea—esophageal cancer	0.000498	0.0104	CbGeAlD
Melatonin—Infection—Carboplatin—esophageal cancer	0.000498	0.0146	CcSEcCtD
Melatonin—MPO—digestive system—esophageal cancer	0.000477	0.00996	CbGeAlD
Melatonin—Nail disorder—Capecitabine—esophageal cancer	0.000468	0.0137	CcSEcCtD
Melatonin—Blood triglycerides increased—Capecitabine—esophageal cancer	0.000463	0.0136	CcSEcCtD
Melatonin—CYP1B1—smooth muscle tissue—esophageal cancer	0.000461	0.00963	CbGeAlD
Melatonin—ESR1—epithelium—esophageal cancer	0.000445	0.00929	CbGeAlD
Melatonin—CALM2—epithelium—esophageal cancer	0.000442	0.00924	CbGeAlD
Melatonin—CALM1—epithelium—esophageal cancer	0.00044	0.00919	CbGeAlD
Melatonin—CALM2—bronchus—esophageal cancer	0.000436	0.0091	CbGeAlD
Melatonin—CALM1—bronchus—esophageal cancer	0.000434	0.00905	CbGeAlD
Melatonin—ESR1—smooth muscle tissue—esophageal cancer	0.000429	0.00895	CbGeAlD
Melatonin—Pain—Carboplatin—esophageal cancer	0.000428	0.0126	CcSEcCtD
Melatonin—CALM2—smooth muscle tissue—esophageal cancer	0.000426	0.0089	CbGeAlD
Melatonin—CALM1—smooth muscle tissue—esophageal cancer	0.000424	0.00886	CbGeAlD
Melatonin—Tongue disorder—Capecitabine—esophageal cancer	0.000417	0.0123	CcSEcCtD
Melatonin—Herpes zoster—Capecitabine—esophageal cancer	0.000403	0.0118	CcSEcCtD
Melatonin—MPO—lung—esophageal cancer	0.000398	0.00831	CbGeAlD
Melatonin—Nabumetone—PTGS2—esophageal cancer	0.000396	0.309	CrCbGaD
Melatonin—CALM2—trachea—esophageal cancer	0.000391	0.00817	CbGeAlD
Melatonin—CALM1—trachea—esophageal cancer	0.000389	0.00813	CbGeAlD
Melatonin—Memory impairment—Capecitabine—esophageal cancer	0.000387	0.0114	CcSEcCtD
Melatonin—CYP1B1—digestive system—esophageal cancer	0.000364	0.0076	CbGeAlD
Melatonin—Psoriasis—Methotrexate—esophageal cancer	0.00036	0.0106	CcSEcCtD
Melatonin—CALM3—lung—esophageal cancer	0.000358	0.00747	CbGeAlD
Melatonin—NQO2—lymph node—esophageal cancer	0.000354	0.00739	CbGeAlD
Melatonin—Nail disorder—Methotrexate—esophageal cancer	0.000348	0.0102	CcSEcCtD
Melatonin—Proteinuria—Capecitabine—esophageal cancer	0.000346	0.0101	CcSEcCtD
Melatonin—Protein urine present—Capecitabine—esophageal cancer	0.000341	0.01	CcSEcCtD
Melatonin—Polyuria—Cisplatin—esophageal cancer	0.000341	0.00999	CcSEcCtD
Melatonin—ESR1—digestive system—esophageal cancer	0.000339	0.00707	CbGeAlD
Melatonin—CYP1A1—epithelium—esophageal cancer	0.000338	0.00707	CbGeAlD
Melatonin—CALM2—digestive system—esophageal cancer	0.000337	0.00703	CbGeAlD
Melatonin—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.000336	0.00987	CcSEcCtD
Melatonin—CALM1—digestive system—esophageal cancer	0.000335	0.00699	CbGeAlD
Melatonin—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000334	0.0098	CcSEcCtD
Melatonin—CYP1A1—bronchus—esophageal cancer	0.000333	0.00696	CbGeAlD
Melatonin—Hypocalcaemia—Capecitabine—esophageal cancer	0.000332	0.00974	CcSEcCtD
Melatonin—Lacrimation increased—Capecitabine—esophageal cancer	0.000329	0.00967	CcSEcCtD
Melatonin—Nocturia—Capecitabine—esophageal cancer	0.000327	0.00961	CcSEcCtD
Melatonin—CYP2C19—digestive system—esophageal cancer	0.00032	0.00667	CbGeAlD
Melatonin—Neck pain—Capecitabine—esophageal cancer	0.000307	0.00902	CcSEcCtD
Melatonin—CYP1B1—lung—esophageal cancer	0.000304	0.00635	CbGeAlD
Melatonin—Hyponatraemia—Cisplatin—esophageal cancer	0.0003	0.00881	CcSEcCtD
Melatonin—Herpes zoster—Methotrexate—esophageal cancer	0.0003	0.00881	CcSEcCtD
Melatonin—CYP1A1—trachea—esophageal cancer	0.000299	0.00625	CbGeAlD
Melatonin—Irritability—Cisplatin—esophageal cancer	0.000285	0.00838	CcSEcCtD
Melatonin—ESR1—lung—esophageal cancer	0.000283	0.0059	CbGeAlD
Melatonin—CALM2—lung—esophageal cancer	0.000281	0.00587	CbGeAlD
Melatonin—CALM1—lung—esophageal cancer	0.00028	0.00584	CbGeAlD
Melatonin—Urine output increased—Capecitabine—esophageal cancer	0.000275	0.00806	CcSEcCtD
Melatonin—Mouth ulceration—Capecitabine—esophageal cancer	0.000275	0.00806	CcSEcCtD
Melatonin—MPO—lymph node—esophageal cancer	0.000272	0.00569	CbGeAlD
Melatonin—Breast disorder—Cisplatin—esophageal cancer	0.00027	0.00793	CcSEcCtD
Melatonin—Nasopharyngitis—Cisplatin—esophageal cancer	0.000267	0.00785	CcSEcCtD
Melatonin—CYP1A2—digestive system—esophageal cancer	0.000261	0.00545	CbGeAlD
Melatonin—CYP1A1—digestive system—esophageal cancer	0.000257	0.00538	CbGeAlD
Melatonin—Proteinuria—Methotrexate—esophageal cancer	0.000257	0.00755	CcSEcCtD
Melatonin—Protein urine present—Methotrexate—esophageal cancer	0.000254	0.00745	CcSEcCtD
Melatonin—Polyuria—Capecitabine—esophageal cancer	0.000251	0.00737	CcSEcCtD
Melatonin—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000249	0.0073	CcSEcCtD
Melatonin—CYP2C9—digestive system—esophageal cancer	0.000248	0.00517	CbGeAlD
Melatonin—Abdominal discomfort—Cisplatin—esophageal cancer	0.000248	0.00727	CcSEcCtD
Melatonin—CALM3—lymph node—esophageal cancer	0.000245	0.00511	CbGeAlD
Melatonin—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000239	0.00701	CcSEcCtD
Melatonin—Hot flush—Capecitabine—esophageal cancer	0.000236	0.00692	CcSEcCtD
Melatonin—Menopausal symptoms—Capecitabine—esophageal cancer	0.000234	0.00686	CcSEcCtD
Melatonin—Thirst—Capecitabine—esophageal cancer	0.000232	0.0068	CcSEcCtD
Melatonin—Arthritis—Capecitabine—esophageal cancer	0.000227	0.00666	CcSEcCtD
Melatonin—Lethargy—Capecitabine—esophageal cancer	0.000225	0.0066	CcSEcCtD
Melatonin—Stomatitis—Cisplatin—esophageal cancer	0.000225	0.00659	CcSEcCtD
Melatonin—CYP19A1—lymph node—esophageal cancer	0.000223	0.00465	CbGeAlD
Melatonin—Hyponatraemia—Capecitabine—esophageal cancer	0.000221	0.0065	CcSEcCtD
Melatonin—Pain in extremity—Capecitabine—esophageal cancer	0.00022	0.00647	CcSEcCtD
Melatonin—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000219	0.00642	CcSEcCtD
Melatonin—CYP1A2—lung—esophageal cancer	0.000218	0.00455	CbGeAlD
Melatonin—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000218	0.0064	CcSEcCtD
Melatonin—Migraine—Capecitabine—esophageal cancer	0.000217	0.00637	CcSEcCtD
Melatonin—CYP1A1—lung—esophageal cancer	0.000215	0.00449	CbGeAlD
Melatonin—Irritability—Capecitabine—esophageal cancer	0.00021	0.00617	CcSEcCtD
Melatonin—Mood swings—Capecitabine—esophageal cancer	0.000209	0.00613	CcSEcCtD
Melatonin—CYP1B1—lymph node—esophageal cancer	0.000208	0.00434	CbGeAlD
Melatonin—Mouth ulceration—Methotrexate—esophageal cancer	0.000204	0.006	CcSEcCtD
Melatonin—Urine output increased—Methotrexate—esophageal cancer	0.000204	0.006	CcSEcCtD
Melatonin—Urinary tract disorder—Cisplatin—esophageal cancer	0.000204	0.006	CcSEcCtD
Melatonin—Liver function test abnormal—Capecitabine—esophageal cancer	0.000203	0.00597	CcSEcCtD
Melatonin—Connective tissue disorder—Cisplatin—esophageal cancer	0.000203	0.00597	CcSEcCtD
Melatonin—Urethral disorder—Cisplatin—esophageal cancer	0.000203	0.00595	CcSEcCtD
Melatonin—Dry skin—Capecitabine—esophageal cancer	0.000202	0.00593	CcSEcCtD
Melatonin—Abdominal pain upper—Capecitabine—esophageal cancer	0.000201	0.00591	CcSEcCtD
Melatonin—Breast disorder—Capecitabine—esophageal cancer	0.000199	0.00585	CcSEcCtD
Melatonin—Nasopharyngitis—Capecitabine—esophageal cancer	0.000197	0.00579	CcSEcCtD
Melatonin—Gastritis—Capecitabine—esophageal cancer	0.000195	0.00573	CcSEcCtD
Melatonin—ESR1—lymph node—esophageal cancer	0.000193	0.00404	CbGeAlD
Melatonin—Eye disorder—Cisplatin—esophageal cancer	0.000193	0.00567	CcSEcCtD
Melatonin—CALM2—lymph node—esophageal cancer	0.000192	0.00401	CbGeAlD
Melatonin—Cardiac disorder—Cisplatin—esophageal cancer	0.000192	0.00563	CcSEcCtD
Melatonin—CALM1—lymph node—esophageal cancer	0.000191	0.004	CbGeAlD
Melatonin—Sumatriptan—ABCB1—esophageal cancer	0.000191	0.149	CrCbGaD
Melatonin—Polyuria—Methotrexate—esophageal cancer	0.000187	0.00548	CcSEcCtD
Melatonin—Immune system disorder—Cisplatin—esophageal cancer	0.000187	0.00548	CcSEcCtD
Melatonin—Angina pectoris—Capecitabine—esophageal cancer	0.000186	0.00545	CcSEcCtD
Melatonin—Abdominal discomfort—Capecitabine—esophageal cancer	0.000183	0.00536	CcSEcCtD
Melatonin—Malnutrition—Cisplatin—esophageal cancer	0.00018	0.00529	CcSEcCtD
Melatonin—Erythema—Cisplatin—esophageal cancer	0.00018	0.00529	CcSEcCtD
Melatonin—Flatulence—Cisplatin—esophageal cancer	0.000177	0.00521	CcSEcCtD
Melatonin—Weight increased—Capecitabine—esophageal cancer	0.000173	0.00509	CcSEcCtD
Melatonin—Muscle spasms—Cisplatin—esophageal cancer	0.000173	0.00508	CcSEcCtD
Melatonin—Infestation—Capecitabine—esophageal cancer	0.00017	0.00499	CcSEcCtD
Melatonin—Infestation NOS—Capecitabine—esophageal cancer	0.00017	0.00499	CcSEcCtD
Melatonin—Vision blurred—Cisplatin—esophageal cancer	0.00017	0.00498	CcSEcCtD
Melatonin—Lethargy—Methotrexate—esophageal cancer	0.000167	0.00491	CcSEcCtD
Melatonin—Stomatitis—Capecitabine—esophageal cancer	0.000166	0.00486	CcSEcCtD
Melatonin—Haematuria—Capecitabine—esophageal cancer	0.000162	0.00475	CcSEcCtD
Melatonin—Leukopenia—Cisplatin—esophageal cancer	0.000161	0.00473	CcSEcCtD
Melatonin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000161	0.00472	CcSEcCtD
Melatonin—Irritability—Methotrexate—esophageal cancer	0.000157	0.0046	CcSEcCtD
Melatonin—Mood swings—Methotrexate—esophageal cancer	0.000155	0.00456	CcSEcCtD
Melatonin—Anxiety—Cisplatin—esophageal cancer	0.000153	0.00448	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000152	0.00447	CcSEcCtD
Melatonin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000151	0.00445	CcSEcCtD
Melatonin—Urinary tract disorder—Capecitabine—esophageal cancer	0.000151	0.00442	CcSEcCtD
Melatonin—Connective tissue disorder—Capecitabine—esophageal cancer	0.00015	0.0044	CcSEcCtD
Melatonin—Urethral disorder—Capecitabine—esophageal cancer	0.000149	0.00439	CcSEcCtD
Melatonin—Breast disorder—Methotrexate—esophageal cancer	0.000148	0.00435	CcSEcCtD
Melatonin—CYP1A1—lymph node—esophageal cancer	0.000147	0.00307	CbGeAlD
Melatonin—Infection—Cisplatin—esophageal cancer	0.000146	0.00429	CcSEcCtD
Melatonin—Nervous system disorder—Cisplatin—esophageal cancer	0.000144	0.00423	CcSEcCtD
Melatonin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000144	0.00422	CcSEcCtD
Melatonin—Skin disorder—Cisplatin—esophageal cancer	0.000143	0.00419	CcSEcCtD
Melatonin—Eye disorder—Capecitabine—esophageal cancer	0.000142	0.00418	CcSEcCtD
Melatonin—Cardiac disorder—Capecitabine—esophageal cancer	0.000142	0.00415	CcSEcCtD
Melatonin—Angiopathy—Capecitabine—esophageal cancer	0.000138	0.00406	CcSEcCtD
Melatonin—Immune system disorder—Capecitabine—esophageal cancer	0.000138	0.00404	CcSEcCtD
Melatonin—Abdominal discomfort—Methotrexate—esophageal cancer	0.000136	0.00399	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000134	0.00393	CcSEcCtD
Melatonin—Mental disorder—Capecitabine—esophageal cancer	0.000134	0.00392	CcSEcCtD
Melatonin—Malnutrition—Capecitabine—esophageal cancer	0.000133	0.0039	CcSEcCtD
Melatonin—Erythema—Capecitabine—esophageal cancer	0.000133	0.0039	CcSEcCtD
Melatonin—Paraesthesia—Cisplatin—esophageal cancer	0.000132	0.00387	CcSEcCtD
Melatonin—Flatulence—Capecitabine—esophageal cancer	0.000131	0.00384	CcSEcCtD
Melatonin—Back pain—Capecitabine—esophageal cancer	0.000128	0.00377	CcSEcCtD
Melatonin—Muscle spasms—Capecitabine—esophageal cancer	0.000128	0.00375	CcSEcCtD
Melatonin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000127	0.00372	CcSEcCtD
Melatonin—Infestation NOS—Methotrexate—esophageal cancer	0.000126	0.00371	CcSEcCtD
Melatonin—Infestation—Methotrexate—esophageal cancer	0.000126	0.00371	CcSEcCtD
Melatonin—Pain—Cisplatin—esophageal cancer	0.000126	0.00369	CcSEcCtD
Melatonin—Vision blurred—Capecitabine—esophageal cancer	0.000125	0.00367	CcSEcCtD
Melatonin—Stomatitis—Methotrexate—esophageal cancer	0.000123	0.00362	CcSEcCtD
Melatonin—Haematuria—Methotrexate—esophageal cancer	0.000121	0.00354	CcSEcCtD
Melatonin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00012	0.00351	CcSEcCtD
Melatonin—Vertigo—Capecitabine—esophageal cancer	0.000119	0.0035	CcSEcCtD
Melatonin—Syncope—Capecitabine—esophageal cancer	0.000119	0.00349	CcSEcCtD
Melatonin—Leukopenia—Capecitabine—esophageal cancer	0.000119	0.00349	CcSEcCtD
Melatonin—Palpitations—Capecitabine—esophageal cancer	0.000117	0.00344	CcSEcCtD
Melatonin—Loss of consciousness—Capecitabine—esophageal cancer	0.000117	0.00342	CcSEcCtD
Melatonin—Hypertension—Capecitabine—esophageal cancer	0.000115	0.00336	CcSEcCtD
Melatonin—Chest pain—Capecitabine—esophageal cancer	0.000113	0.00332	CcSEcCtD
Melatonin—Arthralgia—Capecitabine—esophageal cancer	0.000113	0.00332	CcSEcCtD
Melatonin—Anxiety—Capecitabine—esophageal cancer	0.000113	0.00331	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000112	0.00329	CcSEcCtD
Melatonin—Urinary tract disorder—Methotrexate—esophageal cancer	0.000112	0.00329	CcSEcCtD
Melatonin—Urethral disorder—Methotrexate—esophageal cancer	0.000111	0.00327	CcSEcCtD
Melatonin—Dry mouth—Capecitabine—esophageal cancer	0.000111	0.00324	CcSEcCtD
Melatonin—Hypersensitivity—Cisplatin—esophageal cancer	0.000108	0.00318	CcSEcCtD
Melatonin—Infection—Capecitabine—esophageal cancer	0.000108	0.00316	CcSEcCtD
Melatonin—Shock—Capecitabine—esophageal cancer	0.000107	0.00313	CcSEcCtD
Melatonin—Nervous system disorder—Capecitabine—esophageal cancer	0.000106	0.00312	CcSEcCtD
Melatonin—Eye disorder—Methotrexate—esophageal cancer	0.000106	0.00311	CcSEcCtD
Melatonin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000106	0.00311	CcSEcCtD
Melatonin—Asthenia—Cisplatin—esophageal cancer	0.000105	0.00309	CcSEcCtD
Melatonin—Cardiac disorder—Methotrexate—esophageal cancer	0.000105	0.00309	CcSEcCtD
Melatonin—Skin disorder—Capecitabine—esophageal cancer	0.000105	0.00309	CcSEcCtD
Melatonin—Angiopathy—Methotrexate—esophageal cancer	0.000103	0.00302	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—esophageal cancer	0.000103	0.00301	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—esophageal cancer	9.94e-05	0.00292	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—esophageal cancer	9.88e-05	0.0029	CcSEcCtD
Melatonin—Erythema—Methotrexate—esophageal cancer	9.88e-05	0.0029	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	9.87e-05	0.0029	CcSEcCtD
Melatonin—Insomnia—Capecitabine—esophageal cancer	9.8e-05	0.00288	CcSEcCtD
Melatonin—Paraesthesia—Capecitabine—esophageal cancer	9.73e-05	0.00286	CcSEcCtD
Melatonin—Back pain—Methotrexate—esophageal cancer	9.56e-05	0.00281	CcSEcCtD
Melatonin—Dyspepsia—Capecitabine—esophageal cancer	9.54e-05	0.0028	CcSEcCtD
Melatonin—Gastrointestinal disorder—Capecitabine—esophageal cancer	9.35e-05	0.00275	CcSEcCtD
Melatonin—Vomiting—Cisplatin—esophageal cancer	9.34e-05	0.00274	CcSEcCtD
Melatonin—Fatigue—Capecitabine—esophageal cancer	9.34e-05	0.00274	CcSEcCtD
Melatonin—Vision blurred—Methotrexate—esophageal cancer	9.31e-05	0.00273	CcSEcCtD
Melatonin—Rash—Cisplatin—esophageal cancer	9.27e-05	0.00272	CcSEcCtD
Melatonin—Pain—Capecitabine—esophageal cancer	9.26e-05	0.00272	CcSEcCtD
Melatonin—Dermatitis—Cisplatin—esophageal cancer	9.26e-05	0.00272	CcSEcCtD
Melatonin—Vertigo—Methotrexate—esophageal cancer	8.88e-05	0.00261	CcSEcCtD
Melatonin—Gastrointestinal pain—Capecitabine—esophageal cancer	8.86e-05	0.0026	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—esophageal cancer	8.84e-05	0.0026	CcSEcCtD
Melatonin—Nausea—Cisplatin—esophageal cancer	8.73e-05	0.00256	CcSEcCtD
Melatonin—Abdominal pain—Capecitabine—esophageal cancer	8.56e-05	0.00251	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—esophageal cancer	8.41e-05	0.00247	CcSEcCtD
Melatonin—Chest pain—Methotrexate—esophageal cancer	8.41e-05	0.00247	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	8.35e-05	0.00245	CcSEcCtD
Melatonin—Infection—Methotrexate—esophageal cancer	8.01e-05	0.00235	CcSEcCtD
Melatonin—Hypersensitivity—Capecitabine—esophageal cancer	7.98e-05	0.00234	CcSEcCtD
Melatonin—Nervous system disorder—Methotrexate—esophageal cancer	7.91e-05	0.00232	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—esophageal cancer	7.9e-05	0.00232	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—esophageal cancer	7.83e-05	0.0023	CcSEcCtD
Melatonin—Asthenia—Capecitabine—esophageal cancer	7.77e-05	0.00228	CcSEcCtD
Melatonin—Pruritus—Capecitabine—esophageal cancer	7.66e-05	0.00225	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	7.35e-05	0.00216	CcSEcCtD
Melatonin—Insomnia—Methotrexate—esophageal cancer	7.29e-05	0.00214	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—esophageal cancer	7.24e-05	0.00213	CcSEcCtD
Melatonin—Somnolence—Methotrexate—esophageal cancer	7.17e-05	0.0021	CcSEcCtD
Melatonin—Dizziness—Capecitabine—esophageal cancer	7.16e-05	0.0021	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—esophageal cancer	7.1e-05	0.00208	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—esophageal cancer	6.96e-05	0.00204	CcSEcCtD
Melatonin—Fatigue—Methotrexate—esophageal cancer	6.95e-05	0.00204	CcSEcCtD
Melatonin—Pain—Methotrexate—esophageal cancer	6.9e-05	0.00202	CcSEcCtD
Melatonin—Vomiting—Capecitabine—esophageal cancer	6.89e-05	0.00202	CcSEcCtD
Melatonin—Rash—Capecitabine—esophageal cancer	6.83e-05	0.002	CcSEcCtD
Melatonin—Dermatitis—Capecitabine—esophageal cancer	6.82e-05	0.002	CcSEcCtD
Melatonin—Headache—Capecitabine—esophageal cancer	6.79e-05	0.00199	CcSEcCtD
Melatonin—Gastrointestinal pain—Methotrexate—esophageal cancer	6.59e-05	0.00194	CcSEcCtD
Melatonin—Nausea—Capecitabine—esophageal cancer	6.43e-05	0.00189	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—esophageal cancer	6.37e-05	0.00187	CcSEcCtD
Melatonin—Hypersensitivity—Methotrexate—esophageal cancer	5.94e-05	0.00174	CcSEcCtD
Melatonin—Asthenia—Methotrexate—esophageal cancer	5.79e-05	0.0017	CcSEcCtD
Melatonin—Pruritus—Methotrexate—esophageal cancer	5.71e-05	0.00167	CcSEcCtD
Melatonin—Dizziness—Methotrexate—esophageal cancer	5.33e-05	0.00157	CcSEcCtD
Melatonin—Vomiting—Methotrexate—esophageal cancer	5.13e-05	0.0015	CcSEcCtD
Melatonin—Rash—Methotrexate—esophageal cancer	5.08e-05	0.00149	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—esophageal cancer	5.08e-05	0.00149	CcSEcCtD
Melatonin—Headache—Methotrexate—esophageal cancer	5.05e-05	0.00148	CcSEcCtD
Melatonin—Nausea—Methotrexate—esophageal cancer	4.79e-05	0.00141	CcSEcCtD
Melatonin—CYP2C9—Metabolism—CYP2A6—esophageal cancer	3.23e-06	2.87e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.22e-06	2.86e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—CDKN1A—esophageal cancer	3.22e-06	2.86e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FBXW7—esophageal cancer	3.2e-06	2.85e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FBXW7—esophageal cancer	3.2e-06	2.85e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—HMOX1—esophageal cancer	3.16e-06	2.81e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GNG7—esophageal cancer	3.13e-06	2.79e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—CREBBP—esophageal cancer	3.12e-06	2.78e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—CDKN1A—esophageal cancer	3.11e-06	2.77e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—CDKN1A—esophageal cancer	3.11e-06	2.77e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—CDKN1A—esophageal cancer	3.09e-06	2.75e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—TLR4—esophageal cancer	3.07e-06	2.73e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ENO1—esophageal cancer	3.06e-06	2.73e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS1—esophageal cancer	3.06e-06	2.73e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—EP300—esophageal cancer	3.06e-06	2.72e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—HMOX1—esophageal cancer	3.05e-06	2.72e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—HMOX1—esophageal cancer	3.05e-06	2.72e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—ABCB1—esophageal cancer	3.03e-06	2.7e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PSME1—esophageal cancer	3.02e-06	2.69e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PSME2—esophageal cancer	3.02e-06	2.69e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NOTCH2—esophageal cancer	3.02e-06	2.68e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—HMOX1—esophageal cancer	2.99e-06	2.66e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CDKN1A—esophageal cancer	2.99e-06	2.66e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CDKN1A—esophageal cancer	2.99e-06	2.66e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HIF1A—esophageal cancer	2.97e-06	2.64e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—TLR4—esophageal cancer	2.97e-06	2.64e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—TLR4—esophageal cancer	2.97e-06	2.64e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—EP300—esophageal cancer	2.96e-06	2.64e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—EP300—esophageal cancer	2.96e-06	2.64e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—HIF1A—esophageal cancer	2.96e-06	2.63e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.94e-06	2.61e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ALDH2—esophageal cancer	2.94e-06	2.61e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—ABCB1—esophageal cancer	2.93e-06	2.61e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—ABCB1—esophageal cancer	2.93e-06	2.61e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NOTCH2—esophageal cancer	2.92e-06	2.6e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NOTCH2—esophageal cancer	2.92e-06	2.6e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—NOS3—esophageal cancer	2.9e-06	2.58e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.89e-06	2.57e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—ABCB1—esophageal cancer	2.87e-06	2.56e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—HIF1A—esophageal cancer	2.86e-06	2.55e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—HIF1A—esophageal cancer	2.86e-06	2.55e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CYP1B1—esophageal cancer	2.86e-06	2.54e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KDR—esophageal cancer	2.84e-06	2.53e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GSTT1—esophageal cancer	2.79e-06	2.49e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—NOS3—esophageal cancer	2.79e-06	2.49e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP2A6—esophageal cancer	2.76e-06	2.46e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.75e-06	2.45e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NOS2—esophageal cancer	2.69e-06	2.4e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CYP19A1—esophageal cancer	2.69e-06	2.39e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TGFBR2—esophageal cancer	2.68e-06	2.38e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NOTCH1—esophageal cancer	2.67e-06	2.38e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NOTCH1—esophageal cancer	2.67e-06	2.37e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PTGS2—esophageal cancer	2.65e-06	2.36e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.64e-06	2.35e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CASP8—esophageal cancer	2.63e-06	2.34e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CREBBP—esophageal cancer	2.62e-06	2.33e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ENO1—esophageal cancer	2.62e-06	2.33e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS1—esophageal cancer	2.62e-06	2.33e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—EGFR—esophageal cancer	2.61e-06	2.32e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CYP1B1—esophageal cancer	2.6e-06	2.32e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NOS2—esophageal cancer	2.6e-06	2.32e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NOS2—esophageal cancer	2.6e-06	2.32e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TGFBR2—esophageal cancer	2.59e-06	2.3e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TGFBR2—esophageal cancer	2.59e-06	2.3e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NOTCH1—esophageal cancer	2.58e-06	2.29e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NOTCH1—esophageal cancer	2.58e-06	2.29e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PSME1—esophageal cancer	2.58e-06	2.29e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PSME2—esophageal cancer	2.58e-06	2.29e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PTGS2—esophageal cancer	2.55e-06	2.27e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CASP8—esophageal cancer	2.54e-06	2.26e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CASP8—esophageal cancer	2.54e-06	2.26e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SMAD4—esophageal cancer	2.53e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CREBBP—esophageal cancer	2.53e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CREBBP—esophageal cancer	2.53e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—EGFR—esophageal cancer	2.52e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—EGFR—esophageal cancer	2.52e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—PIK3CA—esophageal cancer	2.52e-06	2.24e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—EGFR—esophageal cancer	2.51e-06	2.23e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—HMOX1—esophageal cancer	2.45e-06	2.18e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SMAD4—esophageal cancer	2.45e-06	2.18e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SMAD4—esophageal cancer	2.45e-06	2.18e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CYP19A1—esophageal cancer	2.45e-06	2.18e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TP53—esophageal cancer	2.43e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—PIK3CA—esophageal cancer	2.43e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—PIK3CA—esophageal cancer	2.43e-06	2.17e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CREBBP—esophageal cancer	2.42e-06	2.16e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—EGFR—esophageal cancer	2.42e-06	2.16e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—EGFR—esophageal cancer	2.42e-06	2.16e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CREBBP—esophageal cancer	2.42e-06	2.15e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.4e-06	2.14e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TP53—esophageal cancer	2.35e-06	2.09e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TP53—esophageal cancer	2.35e-06	2.09e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ABCB1—esophageal cancer	2.35e-06	2.09e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CREBBP—esophageal cancer	2.34e-06	2.08e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CREBBP—esophageal cancer	2.34e-06	2.08e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—PIK3CA—esophageal cancer	2.26e-06	2.02e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—BCL2—esophageal cancer	2.26e-06	2.01e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.25e-06	2e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—HMOX1—esophageal cancer	2.23e-06	1.99e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP1B1—esophageal cancer	2.23e-06	1.98e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—MYC—esophageal cancer	2.21e-06	1.97e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—EP300—esophageal cancer	2.21e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—ERBB2—esophageal cancer	2.19e-06	1.95e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.19e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—PIK3CA—esophageal cancer	2.19e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—PIK3CA—esophageal cancer	2.19e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—BCL2—esophageal cancer	2.18e-06	1.94e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—BCL2—esophageal cancer	2.18e-06	1.94e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—PIK3CA—esophageal cancer	2.17e-06	1.94e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.17e-06	1.93e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NOS3—esophageal cancer	2.17e-06	1.93e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NOS3—esophageal cancer	2.16e-06	1.93e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ABCB1—esophageal cancer	2.14e-06	1.91e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—EP300—esophageal cancer	2.12e-06	1.89e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—ERBB2—esophageal cancer	2.12e-06	1.89e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—ERBB2—esophageal cancer	2.12e-06	1.89e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—PIK3CA—esophageal cancer	2.1e-06	1.87e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—PIK3CA—esophageal cancer	2.1e-06	1.87e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NOS3—esophageal cancer	2.09e-06	1.86e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NOS3—esophageal cancer	2.09e-06	1.86e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.09e-06	1.86e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HIF1A—esophageal cancer	2.07e-06	1.84e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—ERBB2—esophageal cancer	2.03e-06	1.81e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—CREBBP—esophageal cancer	2.02e-06	1.8e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—ERBB2—esophageal cancer	2.02e-06	1.8e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HIF1A—esophageal cancer	2e-06	1.78e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HIF1A—esophageal cancer	2e-06	1.78e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KDR—esophageal cancer	1.98e-06	1.76e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PTGS2—esophageal cancer	1.98e-06	1.76e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—CREBBP—esophageal cancer	1.96e-06	1.74e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—CREBBP—esophageal cancer	1.96e-06	1.74e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—ERBB2—esophageal cancer	1.96e-06	1.74e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—ERBB2—esophageal cancer	1.96e-06	1.74e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—CREBBP—esophageal cancer	1.92e-06	1.71e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KDR—esophageal cancer	1.92e-06	1.71e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KDR—esophageal cancer	1.92e-06	1.71e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTGS2—esophageal cancer	1.92e-06	1.7e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTGS2—esophageal cancer	1.92e-06	1.7e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.91e-06	1.7e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CDKN1A—esophageal cancer	1.87e-06	1.67e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.87e-06	1.67e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NOTCH1—esophageal cancer	1.87e-06	1.66e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.83e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CDKN1A—esophageal cancer	1.81e-06	1.61e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CDKN1A—esophageal cancer	1.81e-06	1.61e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—NOS3—esophageal cancer	1.81e-06	1.61e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NOTCH1—esophageal cancer	1.81e-06	1.61e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NOTCH1—esophageal cancer	1.81e-06	1.61e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCND1—esophageal cancer	1.79e-06	1.6e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—EP300—esophageal cancer	1.78e-06	1.59e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.78e-06	1.58e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—NOS3—esophageal cancer	1.75e-06	1.56e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—NOS3—esophageal cancer	1.75e-06	1.56e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CDKN1A—esophageal cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CDKN1A—esophageal cancer	1.73e-06	1.54e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—EP300—esophageal cancer	1.73e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—EP300—esophageal cancer	1.73e-06	1.53e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—NOS3—esophageal cancer	1.72e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CREBBP—esophageal cancer	1.69e-06	1.51e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CDKN1A—esophageal cancer	1.67e-06	1.49e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CDKN1A—esophageal cancer	1.67e-06	1.49e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EGFR—esophageal cancer	1.66e-06	1.48e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—esophageal cancer	1.66e-06	1.48e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EP300—esophageal cancer	1.65e-06	1.47e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—EP300—esophageal cancer	1.65e-06	1.46e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CREBBP—esophageal cancer	1.64e-06	1.46e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CREBBP—esophageal cancer	1.64e-06	1.46e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CA—esophageal cancer	1.63e-06	1.45e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.62e-06	1.44e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EGFR—esophageal cancer	1.61e-06	1.43e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EGFR—esophageal cancer	1.61e-06	1.43e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—esophageal cancer	1.6e-06	1.43e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—esophageal cancer	1.6e-06	1.43e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—EP300—esophageal cancer	1.59e-06	1.42e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—EP300—esophageal cancer	1.59e-06	1.42e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—esophageal cancer	1.57e-06	1.4e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.57e-06	1.4e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CA—esophageal cancer	1.57e-06	1.4e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—EGFR—esophageal cancer	1.52e-06	1.35e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NOS3—esophageal cancer	1.52e-06	1.35e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—EGFR—esophageal cancer	1.47e-06	1.31e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—EGFR—esophageal cancer	1.47e-06	1.31e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NOS3—esophageal cancer	1.47e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NOS3—esophageal cancer	1.47e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CA—esophageal cancer	1.44e-06	1.28e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—esophageal cancer	1.44e-06	1.28e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—esophageal cancer	1.43e-06	1.28e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.43e-06	1.28e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ERBB2—esophageal cancer	1.42e-06	1.26e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EGFR—esophageal cancer	1.41e-06	1.25e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—NOS3—esophageal cancer	1.41e-06	1.25e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—EGFR—esophageal cancer	1.4e-06	1.25e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CA—esophageal cancer	1.4e-06	1.24e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CA—esophageal cancer	1.4e-06	1.24e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—esophageal cancer	1.39e-06	1.23e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—esophageal cancer	1.39e-06	1.23e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.39e-06	1.23e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—EP300—esophageal cancer	1.38e-06	1.23e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ERBB2—esophageal cancer	1.37e-06	1.22e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ERBB2—esophageal cancer	1.37e-06	1.22e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—EGFR—esophageal cancer	1.36e-06	1.21e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—EGFR—esophageal cancer	1.36e-06	1.21e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—EP300—esophageal cancer	1.33e-06	1.19e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—EP300—esophageal cancer	1.33e-06	1.19e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—PIK3CA—esophageal cancer	1.32e-06	1.17e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—EP300—esophageal cancer	1.31e-06	1.16e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.29e-06	1.15e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—NOS3—esophageal cancer	1.28e-06	1.14e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PIK3CA—esophageal cancer	1.28e-06	1.14e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PIK3CA—esophageal cancer	1.28e-06	1.14e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—esophageal cancer	1.25e-06	1.11e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.22e-06	1.09e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CA—esophageal cancer	1.22e-06	1.09e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3CA—esophageal cancer	1.22e-06	1.08e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1A—esophageal cancer	1.21e-06	1.08e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—esophageal cancer	1.21e-06	1.08e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—esophageal cancer	1.21e-06	1.08e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—esophageal cancer	1.18e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CA—esophageal cancer	1.18e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CA—esophageal cancer	1.18e-06	1.05e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.17e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1A—esophageal cancer	1.17e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1A—esophageal cancer	1.17e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EP300—esophageal cancer	1.15e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EP300—esophageal cancer	1.12e-06	9.92e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EP300—esophageal cancer	1.12e-06	9.92e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—NOS3—esophageal cancer	1.1e-06	9.76e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—EP300—esophageal cancer	1.07e-06	9.53e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CA—esophageal cancer	1.02e-06	9.08e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—esophageal cancer	1e-06	8.94e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—esophageal cancer	1e-06	8.92e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CA—esophageal cancer	9.87e-07	8.78e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CA—esophageal cancer	9.87e-07	8.78e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGFR—esophageal cancer	9.83e-07	8.74e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—EP300—esophageal cancer	9.76e-07	8.69e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—esophageal cancer	9.72e-07	8.65e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—esophageal cancer	9.72e-07	8.65e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CA—esophageal cancer	9.68e-07	8.61e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGFR—esophageal cancer	9.51e-07	8.46e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGFR—esophageal cancer	9.51e-07	8.46e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CA—esophageal cancer	8.53e-07	7.59e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—EP300—esophageal cancer	8.34e-07	7.42e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—esophageal cancer	8.25e-07	7.34e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CA—esophageal cancer	8.25e-07	7.34e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CA—esophageal cancer	8.25e-07	7.34e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—esophageal cancer	7.98e-07	7.1e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—esophageal cancer	7.98e-07	7.1e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CA—esophageal cancer	7.92e-07	7.05e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CA—esophageal cancer	7.22e-07	6.43e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CA—esophageal cancer	6.17e-07	5.49e-06	CbGpPWpGaD
